Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876533 · ClinicalTrials.gov registry record
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
A clinical trial of Chronic Heart Failure, sponsored by Cordio Medical.
- Active
- Registry status
- 216
- Enrollment target
- 8
- Study locations
NCT05876533 is a study of Chronic Heart Failure that is active but no longer recruiting, run by Cordio Medical. The registered enrollment target is 216 participants, below the 404-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (47% lower). The trial reports 8 study locations across 4 states.
The verdict
NCT05876533, a study of Chronic Heart Failure, is active but no longer recruiting, sponsored by Cordio Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 216 participants
- Enrollment target
- 8
- Study locations
Study Summary
To determine the usability and technical aspects of Cordio HearO™
Conditions Studied
Interventions
- DEVICE Cordio HearO
Study Locations (8)
Florida
- C&R Research Services - Cape Coral
- C&R Research Services - Miami
- C&R Research Services - Miami
Other
- Barzilai Medical Center- Cardiology - Ashkelon
- Heart Failure Clinic - Clallit Be'er Sheva - Beersheba
- Rabin Medical Center - Cardiology- CHF - Petah Tikva
Connecticut
- Kurker Family Medicine - South Windsor
Georgia
- Lake County Med Grp - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2022-03-18 |
| Est. Completion | 2025-03-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05876533
The ClinicalTrials.gov registry entry for NCT05876533 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 404-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (47% lower). The listed sponsor is Cordio Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Cordio HearO is the first listed.
NCT05876533 reports 8 study locations spanning 4 distinct geographic areas - top geographies include Florida, Other, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05876533 about?
NCT05876533 is a clinical study titled "R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances". To determine the usability and technical aspects of Cordio HearO™
What is the current status of trial NCT05876533?
This trial is currently active not recruiting. The enrollment target is 216 participants. The study started on 2022-03-18. Estimated completion is 2025-03-15.
What conditions does trial NCT05876533 study?
This clinical trial studies the following conditions: Chronic Heart Failure.
What interventions are being tested in trial NCT05876533?
The interventions under investigation include: Cordio HearO (DEVICE).
Who is sponsoring clinical trial NCT05876533?
This trial is sponsored by Cordio Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05876533 being conducted?
This trial has 8 study locations across Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
RECRUITING · NA
-
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
RECRUITING · NA
-
The HEARTFELT Study
RECRUITING · NA
-
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
RECRUITING · Phase 3
-
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.